Mostafa Yakoot
Green Clinic And Research Center
Alexandria, ALX, Egypt
Alexandria, ALX, Egypt
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Nonsignificant trends in COVID-19 trials: Is there a significance?
Journal: Journal of medical virology
Published: October 25, 2021
Treatment of Chronic Hepatitis C in Adolescent Patients With Positive HBsAg or With Occult Hepatitis B: Is the Risk of Hepatitis B Reactivation Significant?
Journal: The Pediatric infectious disease journal
Published: September 14, 2020
Follow-up of chronic paediatric hepatitis C virus in a low-/middle-income country.
Journal: Acta paediatrica (Oslo, Norway : 1992)
Published: January 25, 2020
Effects of sofosbuvir/ledipasvir therapy on chronic hepatitis C virus genotype 4, infected children of 3-6 years of age.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: August 06, 2019
Effects of Dual Sofosbuvir/Daclatasvir Therapy on Weight and Linear Growth in Adolescent Patients with Chronic Hepatitis C Virus Infection.
Journal: The Pediatric infectious disease journal
Published: June 14, 2019
Effects of dual sofosbuvir/daclatasvir therapy on, chronic hepatitis C infected, survivors of childhood malignancy.
Journal: World journal of clinical cases
Published: April 10, 2019
Efficacy of a new local limb salvage treatment for limb-threatening diabetic foot wounds - a randomized controlled study.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: March 31, 2019
Effectiveness of 8-week sofosbuvir/ledipasvir in the adolescent chronic hepatitis C-infected patients.
Journal: European journal of gastroenterology & hepatology
Published: January 25, 2019
Dual Sofosbuvir/Daclatasvir Therapy in Adolescent Patients With Chronic Hepatitis C Infection.
Journal: Journal of pediatric gastroenterology and nutrition
Published: March 24, 2018
A pilot single arm observational study of sofosbuvir/ledipasvir (200 + 45 mg) in 6- to 12- year old children.
Journal: Alimentary pharmacology & therapeutics
Published: January 26, 2018
Shortened 8 Weeks Course of Dual Sofosbuvir/Daclatasvir Therapy in Adolescent Patients, With Chronic Hepatitis C Infection.
Journal: Journal of pediatric gastroenterology and nutrition
Published: November 15, 2017
Last Updated: 09/26/2026